Solid microneedle booster as an enhanced microneedling platform for the treatment of androgenetic alopecia
Drug Delivery and Translational Research · 02.06.2026
DOI: 10.1007/s13346-026-02159-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 02.06.2026. Verfasst von Jiwoo Shin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Yonsei University, Building 123, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Korea Institute for Advancement of Technology, Seoul RISE Center.
Abstract (Originalsprache)
Solid microneedle (SMN) is used to enhance transfollicular delivery in androgenetic alopecia (AGA); however, user-dependent kinematics can generate irregular microchannels that require sequential drug application. Here, we developed a one-step solid microneedle booster (SMB) that combines spring-driven perpendicular stamping with simultaneous liquid dosing. This circumvents the spatial and temporal mismatch inherent in traditional two-step methods, improving microchannel reproducibility and early transport. In porcine skin, rhodamine B mapping exhibited higher microchannel surface coverage for SMB than that of the roller at 20 matched applications, with SMB producing deeper penetration. Functional delivery was evaluated by Franz diffusion using ascorbic acid as a hydrophilic probe of microchannel-assisted permeation. Across the various tested conditions, SMB consistently produced a stronger early-phase permeation enhancement than that of the roller, and this early advantage was reflected in the cumulative delivery at later time points. SMB-assisted minoxidil (MXD) delivery accelerated hair regrowth in vivo compared with roller-assisted delivery under matched treatment settings, and histological analysis supported these outcomes as it revealed a greater enrichment of deep follicles in the SMB + MXD groups. Collectively, SMB provides a directionality-controlled, one-step microneedling platform that enhances the early, front-loaded transport and promotes follicular maturation, with AGA serving as a representative model for the broader applications of dermatologic delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Yonsei University, Building 123, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
- Department of Integrative Biotechnology, Building 123, Yonsei University, 85, Songdogwahak-ro, Incheon, 21983, Korea.
- Juvic Inc, 272 Digital-ro, Guro-gu, Seoul, 08389, Korea.
- Department of Biotechnology, Yonsei University, Building 123, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. hijung@yonsei.ac.kr.
- Department of Integrative Biotechnology, Building 123, Yonsei University, 85, Songdogwahak-ro, Incheon, 21983, Korea. hijung@yonsei.ac.kr.
Förderung
- Korea Institute for Advancement of Technology
- Seoul RISE Center
Zitieren
APA
Shin, J., Song, J., Kim, P., Yang, H., & Jung, H. (2026). Solid microneedle booster as an enhanced microneedling platform for the treatment of androgenetic alopecia. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-026-02159-w
Vancouver
Shin J, Song J, Kim P, Yang H, Jung H. Solid microneedle booster as an enhanced microneedling platform for the treatment of androgenetic alopecia. Drug Delivery and Translational Research. 2026. doi:10.1007/s13346-026-02159-w
BibTeX
@article{Shin2026,
author = {Shin, Jiwoo and Song, Jinhyeok and Kim, Paul and Yang, Huisuk and Jung, Hyungil},
title = {Solid microneedle booster as an enhanced microneedling platform for the treatment of androgenetic alopecia},
journal = {Drug Delivery and Translational Research},
year = {2026},
doi = {10.1007/s13346-026-02159-w}
}
EUVIMED